Old Web
English
Sign In
Acemap
>
Paper
>
Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease: Is the Difference Real?
2018
Tamara Mogilevski
Miles P. Sparrow
Keywords:
Medicine
Infliximab
Adalimumab
Crohn's disease
Internal medicine
Endocrinology
in patient
Hepatology
Transplant surgery
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
13
References
2
Citations
NaN
KQI
[]